Literature DB >> 10355381

Diabetes and hypertension in Mexican American families: relation to cardiovascular risk.

B D Mitchell1, L A Almasy, D L Rainwater, J L Schneider, J Blangero, M P Stern, J W MacCluer.   

Abstract

There is a strong familial predisposition to type 2 diabetes, hypertension, and cardiovascular disease. The authors evaluated the association between a family history of these diseases and a large panel of cardiovascular risk factors in 1,431 Mexican American subjects who were enrolled in the San Antonio Family Heart Study in San Antonio, Texas. The baseline phase of the study covered 1992-1996. Diabetes and hypertension were diagnosed according to standard clinical criteria, while cardiovascular disease was defined as a history of heart attack or heart surgery. The prevalence of diabetes, hypertension, and cardiovascular disease in this population was 15%, 12%, and 3%, respectively. For each unaffected subject, the authors computed a family history score based on the presence or absence of disease in parents and older siblings, and correlations between cardiovascular risk factors and family history scores were estimated by using likelihood-based variance component methods. Diabetes family history score was significantly correlated with a broad panel of cardiovascular risk factors, including glucose and insulin, obesity, blood pressure, triglycerides, and total cholesterol. Hypertension family history score was significantly correlated with glucose, blood pressure, body mass index, waist circumference, total cholesterol, and triglycerides. These results support the idea that genes that confer a risk for diabetes, and to a lesser extent hypertension, adversely alter the cardiovascular risk profile long before the manifestation of clinical disease.

Entities:  

Mesh:

Year:  1999        PMID: 10355381     DOI: 10.1093/oxfordjournals.aje.a009750

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  18 in total

Review 1.  Genetic determinants of diabetes and atherosclerosis.

Authors:  Braxton D Mitchell; Ikhide G Imumorin
Journal:  Curr Atheroscler Rep       Date:  2002-05       Impact factor: 5.113

2.  Human plasma lipidome is pleiotropically associated with cardiovascular risk factors and death.

Authors:  Claire Bellis; Hemant Kulkarni; Manju Mamtani; Jack W Kent; Gerard Wong; Jacquelyn M Weir; Christopher K Barlow; Vincent Diego; Marcio Almeida; Thomas D Dyer; Harald H H Göring; Laura Almasy; Michael C Mahaney; Anthony G Comuzzie; Sarah Williams-Blangero; Peter J Meikle; John Blangero; Joanne E Curran
Journal:  Circ Cardiovasc Genet       Date:  2014-11-02

3.  Plasma lipidome is independently associated with variability in metabolic syndrome in Mexican American families.

Authors:  Hemant Kulkarni; Peter J Meikle; Manju Mamtani; Jacquelyn M Weir; Marcio Almeida; Vincent Diego; Juan Manuel Peralta; Christopher K Barlow; Claire Bellis; Thomas D Dyer; Laura Almasy; Michael C Mahaney; Anthony G Comuzzie; Harald H H Göring; Joanne E Curran; John Blangero
Journal:  J Lipid Res       Date:  2014-03-13       Impact factor: 5.922

4.  The lipidome in major depressive disorder: Shared genetic influence for ether-phosphatidylcholines, a plasma-based phenotype related to inflammation, and disease risk.

Authors:  E E M Knowles; K Huynh; P J Meikle; H H H Göring; R L Olvera; S R Mathias; R Duggirala; L Almasy; J Blangero; J E Curran; D C Glahn
Journal:  Eur Psychiatry       Date:  2017-02-21       Impact factor: 5.361

5.  Chemerin, a novel adipokine in the regulation of angiogenesis.

Authors:  Kiymet Bozaoglu; Joanne E Curran; Claire J Stocker; Mohamed S Zaibi; David Segal; Nicky Konstantopoulos; Shona Morrison; Melanie Carless; Thomas D Dyer; Shelley A Cole; Harald H H Goring; Eric K Moses; Ken Walder; Michael A Cawthorne; John Blangero; Jeremy B M Jowett
Journal:  J Clin Endocrinol Metab       Date:  2010-03-17       Impact factor: 5.958

Review 6.  The economic consequences of diabetes and cardiovascular disease in the United States.

Authors:  Miguel A Ariza; Varsha G Vimalananda; James L Rosenzweig
Journal:  Rev Endocr Metab Disord       Date:  2010-03       Impact factor: 6.514

7.  Infant feeding practices and maternal dietary intake among Latino immigrants in California.

Authors:  Sylvia Guendelman; Anna Maria Siega-Riz
Journal:  J Immigr Health       Date:  2002-07

8.  Serum phosphatidylinositol as a biomarker for bipolar disorder liability.

Authors:  Emma Em Knowles; Peter J Meikle; Kevin Huynh; Harald Hh Göring; Rene L Olvera; Samuel R Mathias; Ravi Duggirala; Laura Almasy; John Blangero; Joanne E Curran; David C Glahn
Journal:  Bipolar Disord       Date:  2017-02-23       Impact factor: 6.744

9.  Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population.

Authors:  Kiymet Bozaoglu; David Segal; Katherine A Shields; Nik Cummings; Joanne E Curran; Anthony G Comuzzie; Michael C Mahaney; David L Rainwater; John L VandeBerg; Jean W MacCluer; Greg Collier; John Blangero; Ken Walder; Jeremy B M Jowett
Journal:  J Clin Endocrinol Metab       Date:  2009-05-26       Impact factor: 5.958

10.  Plasma levels of soluble interleukin 1 receptor accessory protein are reduced in obesity.

Authors:  Kiymet Bozaoglu; Chantal Attard; Hemant Kulkarni; Nik Cummings; Vincent P Diego; Melanie A Carless; Katherine A Shields; Matthew P Johnson; Sudhir Kowlessur; Thomas D Dyer; Anthony G Comuzzie; Laura Almasy; Paul Zimmet; Eric K Moses; Harald H H Göring; Joanne E Curran; John Blangero; Jeremy B M Jowett
Journal:  J Clin Endocrinol Metab       Date:  2014-06-10       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.